Anyplex™ II MTB/MDR Detection

Simultaneous detection of MTB and 25 mutations associated with MDR-TB using real-time PCR

Anyplex™II MTB/MDR Detection simultaneously detects and identifies Mycobacterium tuberculosis (MTB) and 25 mutations associated with MDR-TB. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.

FEATURES

Multiplex real-time PCR

Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB

UDG system

Utilization of the UDG system to prevent carry-over contamination

Wide range of specimens

Wide range of applicable specimens

Automatic data analyzer

Automated data interpretation and LIS interlocking with Seegene Viewer

Wild-type Control

WTC (Wild-type Control) and Internal Control (IC) for assay validity

Prediction of antibiotic resistance

Detection and identification of mutations associated antibiotic resistance for appropriate infection control

Fast treatment decision

Fast treatment decision by simultaneous screening and subtyping

Powerful performance with unique technology

Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies

Visitors Count: 8165